Businessweek

Kraig Biocraft Laboratories, Inc. announced plans to launch its initial commercial production of Monster Silk(TM). The announcement of the company's decision to launch commercial production follows the early successes of its of Monster Silk(TM) pilot production program. Kraig's pilot production program will continue to run, in order to supply continuing data and help grow the company's production capacity.

Kraig Biocraft Laboratories, Inc. announced that at its AGM held on April 16, 2013, the shareholders approved the all three amendments to company's charter. The amendments were designed to help management advance the business model in a more streamlined fashion.

Kraig Biocraft Laboratories, Inc., Annual General Meeting, Apr 16, 2013.

On 04/01/2013, Kraig Biocraft Laboratories, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.

Kraig Biocraft Laboratories, Inc. announced the launch of stage 3 of its pilot production program. The program is designed to run in three stages, each launching in turn when the data from the previous stage indicates that the program is reaching its benchmarks.